137 related articles for article (PubMed ID: 18778950)
1. Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia.
Alibhai SM; Leach M; Gupta V; Tomlinson GA; Brandwein JM; Saiz FS; Minden MD
Crit Rev Oncol Hematol; 2009 Feb; 69(2):168-74. PubMed ID: 18778950
[TBL] [Abstract][Full Text] [Related]
2. The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults.
Alibhai SM; Leach M; Kermalli H; Gupta V; Kowgier ME; Tomlinson GA; Brandwein J; Buckstein R; Minden MD
Crit Rev Oncol Hematol; 2007 Oct; 64(1):19-30. PubMed ID: 17765568
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.
Alibhai SM; Breunis H; Timilshina N; Brignardello-Petersen R; Tomlinson G; Mohamedali H; Gupta V; Minden MD; Li M; Buckstein R; Brandwein JM
J Geriatr Oncol; 2015 Jul; 6(4):262-71. PubMed ID: 25944029
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and quality of care in acute myeloid leukemia over 40 years.
Alibhai SM; Leach M; Minden MD; Brandwein J
Cancer; 2009 Jul; 115(13):2903-11. PubMed ID: 19452536
[TBL] [Abstract][Full Text] [Related]
5. Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia.
Mohamedali H; Breunis H; Timilshina N; Brandwein JM; Gupta V; Minden MD; Li M; Tomlinson G; Buckstein R; Alibhai SM
Leuk Res; 2012 Oct; 36(10):1241-8. PubMed ID: 22727251
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
7. Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.
Rodriguez CP; Baz R; Jawde RA; Rybicki LA; Kalaycio ME; Advani A; Sobecks R; Sekeres MA
Leuk Res; 2008 Mar; 32(3):413-20. PubMed ID: 17727945
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
10. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
11. Outcome in elderly acute myeloid leukaemia.
Osman H; Murray M; Egan E; O'Dwyer M
Ir Med J; 2008; 101(10):307-10. PubMed ID: 19205141
[TBL] [Abstract][Full Text] [Related]
12. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
13. Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.
Latagliata R; Breccia M; Fazi P; Iacobelli S; Martinelli G; Di Raimondo F; Sborgia M; Fabbiano F; Pirrotta MT; Zaccaria A; Amadori S; Caramatti C; Falzetti F; Candoni A; Mattei D; Morselli M; Alimena G; Vignetti M; Baccarani M; Mandelli F
Br J Haematol; 2008 Dec; 143(5):681-9. PubMed ID: 18950458
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
[TBL] [Abstract][Full Text] [Related]
16. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
17. Quality of life outcomes are equivalent after lobectomy in the elderly.
Burfeind WR; Tong BC; O'Branski E; Herndon JE; Toloza EM; D'Amico TA; Harpole LH; Harpole DH
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):597-604. PubMed ID: 18805257
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
[TBL] [Abstract][Full Text] [Related]
19. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome.
Sekeres MA; Stone RM; Zahrieh D; Neuberg D; Morrison V; De Angelo DJ; Galinsky I; Lee SJ
Leukemia; 2004 Apr; 18(4):809-16. PubMed ID: 14762444
[TBL] [Abstract][Full Text] [Related]
20. Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis.
Yuh B; Butt Z; Fazili A; Piacente P; Tan W; Wilding G; Mohler J; Guru K
BJU Int; 2009 Mar; 103(6):800-4. PubMed ID: 19021613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
